<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39353909</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Endosomal fusion of pH-dependent enveloped viruses requires ion channel TRPM7.</ArticleTitle><Pagination><StartPage>8479</StartPage><MedlinePgn>8479</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8479</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-52773-w</ELocationID><Abstract><AbstractText>The majority of viruses classified as pandemic threats are enveloped viruses which enter the cell through receptor-mediated endocytosis and take advantage of endosomal acidification to activate their fusion machinery. Here we report that the endosomal fusion of low pH-requiring viruses is highly dependent on TRPM7, a widely expressed TRP channel that is located on the plasma membrane and in intracellular vesicles. Using several viral infection systems expressing the envelope glycoproteins of various viruses, we find that loss of TRPM7 protects cells from infection by Lassa, LCMV, Ebola, Influenza, MERS, SARS-CoV-1, and SARS-CoV-2. TRPM7 ion channel activity is intrinsically necessary to acidify virus-laden endosomes but is expendable for several other endosomal acidification pathways. We propose a model wherein TRPM7 ion channel activity provides a countercurrent of cations from endosomal lumen to cytosol necessary to sustain the pumping of protons into these virus-laden endosomes. This study demonstrates the possibility of developing a broad-spectrum, TRPM7-targeting antiviral drug to subvert the endosomal fusion of low pH-dependent enveloped viruses.</AbstractText><CopyrightInformation>Â© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Doyle</LastName><ForeName>Catherine A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0002-5415-2371</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busey</LastName><ForeName>Gregory W</ForeName><Initials>GW</Initials><Identifier Source="ORCID">0000-0002-4589-682X</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iobst</LastName><ForeName>Wesley H</ForeName><Initials>WH</Initials><Identifier Source="ORCID">0000-0003-3129-4542</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiessling</LastName><ForeName>Volker</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-9388-5703</Identifier><AffiliationInfo><Affiliation>Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renken</LastName><ForeName>Chloe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doppalapudi</LastName><ForeName>Hansa</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stremska</LastName><ForeName>Marta E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manjegowda</LastName><ForeName>Mohan C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arish</LastName><ForeName>Mohd</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Disease and International Health, Department of Medicine, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Weiming</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nikegen Inc., Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naphade</LastName><ForeName>Shardul</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0000-7977-0873</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloyet</LastName><ForeName>Louis-Marie</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0002-5648-3190</Identifier><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Cassandra E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0001-6273-8113</Identifier><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothlauf</LastName><ForeName>Paul W</ForeName><Initials>PW</Initials><Identifier Source="ORCID">0000-0002-0941-4467</Identifier><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Virology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stipes</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whelan</LastName><ForeName>Sean P J</ForeName><Initials>SPJ</Initials><Identifier Source="ORCID">0000-0003-1564-8590</Identifier><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamm</LastName><ForeName>Lukas K</ForeName><Initials>LK</Initials><Identifier Source="ORCID">0000-0002-1674-4464</Identifier><AffiliationInfo><Affiliation>Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kreutzberger</LastName><ForeName>Alex J B</ForeName><Initials>AJB</Initials><Identifier Source="ORCID">0000-0002-9774-115X</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston Children's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2347-4511</Identifier><AffiliationInfo><Affiliation>Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Disease and International Health, Department of Medicine, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Bimal N</ForeName><Initials>BN</Initials><Identifier Source="ORCID">0000-0002-3928-5854</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, University of Virginia, Charlottesville, VA, USA. bdesai@virginia.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA, USA. bdesai@virginia.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA, USA. bdesai@virginia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI163019</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI154598</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency><Country /></Grant><Grant><GrantID>R01 AG069264</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM108989</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</Agency><Country /></Grant><Grant><GrantID>R01 AI147394</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI163019</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency><Country /></Grant><Grant><GrantID>R01 HL170961</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI030557</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI030557</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency><Country /></Grant><Grant><GrantID>T32 GM007055</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI154598</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM108989</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL170961</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country /></Grant><Grant><GrantID>AI155808</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency><Country /></Grant><Grant><GrantID>AI147394</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency><Country /></Grant><Grant><GrantID>T32 GM007267</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007245</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI112844</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency><Country /></Grant><Grant><GrantID>R01 AI155808</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AI030557</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI112844</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050053">TRPM Cation Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C486583">TRPM7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D050053" MajorTopicYN="Y">TRPM Cation Channels</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011992" MajorTopicYN="Y">Endosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="Y">Virus Internalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029043" MajorTopicYN="N">Ebolavirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008217" MajorTopicYN="N">Lymphocytic choriomeningitis virus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086942" MajorTopicYN="N">Viral Envelope</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007836" MajorTopicYN="N">Lassa virus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>S.P.J.W. is a consultant for Thylacine Biosciences and receives support from Vir Biotechnology to study the properties of VSV-coronavirus chimeras unrelated to this project. J.S. receives support for research unrelated to this project from Icosavax. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39353909</ArticleId><ArticleId IdType="pmc">PMC11445543</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-52773-w</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-52773-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mercer, J., Schelhaas, M. &amp; Helenius, A. Virus entry by endocytosis. Annu. Rev. Biochem.79, 803â833 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20196649</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamauchi, Y. &amp; Helenius, A. Virus entry at a glance. J. Cell Sci.126, 1289â1295 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23641066</ArticleId></ArticleIdList></Reference><Reference><Citation>White, J. M. &amp; Whittaker, G. R. Fusion of enveloped viruses in endosomes. Traffic17, 593â614 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4866878</ArticleId><ArticleId IdType="pubmed">26935856</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigant, F., Santos, N. C. &amp; Lee, B. Broad-spectrum antivirals against viral fusion. Nat. Rev. Microbiol.13, 426â437 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4554337</ArticleId><ArticleId IdType="pubmed">26075364</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisskirchen, K., Lucifora, J., Michler, T. &amp; Protzer, U. New pharmacological strategies to fight enveloped viruses. Trends Pharm. Sci.35, 470â478 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112871</ArticleId><ArticleId IdType="pubmed">25108320</ArticleId></ArticleIdList></Reference><Reference><Citation>White, J. M. et al. Drug combinations as a first line of defense against coronaviruses and other emerging viruses. mBio12, e0334721 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689562</ArticleId><ArticleId IdType="pubmed">34933447</ArticleId></ArticleIdList></Reference><Reference><Citation>White, J., Kartenbeck, J. &amp; Helenius, A. Fusion of Semliki forest virus with the plasma membrane can be induced by low pH. J. Cell Biol.87, 264â272 (1980).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2110712</ArticleId><ArticleId IdType="pubmed">7419594</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz, R., Stiasny, K. &amp; Heinz, F. X. Identification of specific histidines as pH sensors in flavivirus membrane fusion. J. Cell Biol.183, 353â361 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2568029</ArticleId><ArticleId IdType="pubmed">18936253</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J., Gregory, S. M., Nelson, E. A., White, J. M. &amp; Tamm, L. K. The roles of histidines and charged residues as potential triggers of a conformational change in the fusion loop of ebola virus glycoprotein. PLoS One11, e0152527 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4811418</ArticleId><ArticleId IdType="pubmed">27023721</ArticleId></ArticleIdList></Reference><Reference><Citation>Brecher, M. et al. Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change. J. Virol.86, 364â372 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3255896</ArticleId><ArticleId IdType="pubmed">22031933</ArticleId></ArticleIdList></Reference><Reference><Citation>Schornberg, K. et al. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol.80, 4174â4178 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1440424</ArticleId><ArticleId IdType="pubmed">16571833</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons, G. et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. USA102, 11876â11881 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1188015</ArticleId><ArticleId IdType="pubmed">16081529</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, L., Wu, D., Robinson, C. V., Wu, H. &amp; Fu, T. M. Structures of a complete human V-ATPase reveal mechanisms of its assembly. Mol. Cell80, 501â511.e503 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7655608</ArticleId><ArticleId IdType="pubmed">33065002</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey, J. R., Grinstein, S. &amp; Orlowski, J. Sensors and regulators of intracellular pH. Nat. Rev. Mol. Cell Biol.11, 50â61 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">19997129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadwick, S. R., Grinstein, S. &amp; Freeman, S. A. From the inside out: Ion fluxes at the centre of endocytic traffic. Curr. Opin. Cell Biol.71, 77â86 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33706237</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe, K. &amp; Puertollano, R. Role of TRP channels in the regulation of the endosomal pathway. Physiol. (Bethesda)26, 14â22 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3408074</ArticleId><ArticleId IdType="pubmed">21357899</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, H. &amp; Ren, D. Lysosomal physiology. Annu. Rev. Physiol.77, 57â80 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524569</ArticleId><ArticleId IdType="pubmed">25668017</ArticleId></ArticleIdList></Reference><Reference><Citation>Clapham, D. E. TRP channels as cellular sensors. Nature426, 517â524 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14654832</ArticleId></ArticleIdList></Reference><Reference><Citation>Clapham, D. E. SnapShot: mammalian TRP channels. Cell129, 220 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17418797</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatachalam, K. &amp; Montell, C. TRP channels. Annu. Rev. Biochem.76, 387â417 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4196875</ArticleId><ArticleId IdType="pubmed">17579562</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong, X. P. et al. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature455, 992â996 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4301259</ArticleId><ArticleId IdType="pubmed">18794901</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, P., Gu, M. &amp; Xu, H. Lysosomal ion channels as decoders of cellular signals. Trends Biochem. Sci.44, 110â124 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6340733</ArticleId><ArticleId IdType="pubmed">30424907</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadler, M. J. et al. LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature411, 590â595 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11385574</ArticleId></ArticleIdList></Reference><Reference><Citation>Runnels, L. W., Yue, L. &amp; Clapham, D. E. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science291, 1043â1047 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11161216</ArticleId></ArticleIdList></Reference><Reference><Citation>Abiria, S. A. et al. TRPM7 senses oxidative stress to release Zn2+ from unique intracellular vesicles. Proc. Natl. Acad. Sci. USA114, E6079âE6088 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5544332</ArticleId><ArticleId IdType="pubmed">28696294</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelkmans, L. et al. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature436, 78â86 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15889048</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteilh-Zoller, M. K. et al. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J. Gen. Physiol.121, 49â60 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2217320</ArticleId><ArticleId IdType="pubmed">12508053</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, J., Li, M. &amp; Yue, L. Potentiation of TRPM7 inward currents by protons. J. Gen. Physiol.126, 137â150 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2266571</ArticleId><ArticleId IdType="pubmed">16009728</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, J. et al. Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2+ homeostasis. Science322, 756â760 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2605283</ArticleId><ArticleId IdType="pubmed">18974357</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, J. et al. The channel kinase, TRPM7, is required for early embryonic development. Proc. Natl. Acad. Sci. USA109, E225âE233 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277139</ArticleId><ArticleId IdType="pubmed">22203997</ArticleId></ArticleIdList></Reference><Reference><Citation>Sah, R. et al. Timing of myocardial trpm7 deletion during cardiogenesis variably disrupts adult ventricular function, conduction, and repolarization. Circulation128, 101â114 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3800036</ArticleId><ArticleId IdType="pubmed">23734001</ArticleId></ArticleIdList></Reference><Reference><Citation>Schappe, M. S. et al. Chanzyme TRPM7 mediates the Ca(2+) influx essential for lipopolysaccharide-induced toll-like receptor 4 endocytosis and macrophage activation. Immunity48, 59â74.e55 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5783319</ArticleId><ArticleId IdType="pubmed">29343440</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendu, S. K. et al. Targeting the ion channel TRPM7 promotes the thymic development of regulatory T cells by promoting IL-2 signaling. Sci. Signal.13, eabb0619 (2020)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884026</ArticleId><ArticleId IdType="pubmed">33293462</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai, B. N. et al. Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis. Dev. Cell22, 1149â1162 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3397829</ArticleId><ArticleId IdType="pubmed">22698280</ArticleId></ArticleIdList></Reference><Reference><Citation>Krapivinsky, G., Krapivinsky, L., Manasian, Y. &amp; Clapham, D. E. The TRPM7 chanzyme is cleaved to release a chromatin-modifying kinase. Cell157, 1061â1072 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4156102</ArticleId><ArticleId IdType="pubmed">24855944</ArticleId></ArticleIdList></Reference><Reference><Citation>Schappe, M. S. et al. Efferocytosis requires periphagosomal Ca(2+)-signaling and TRPM7-mediated electrical activity. Nat. Commun.13, 3230 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9184625</ArticleId><ArticleId IdType="pubmed">35680919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, Y. L. et al. Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2. Proc. Natl. Acad. Sci. USA117, 20803â20813 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7456157</ArticleId><ArticleId IdType="pubmed">32764148</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurai, Y. et al. Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science347, 995â998 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4550587</ArticleId><ArticleId IdType="pubmed">25722412</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunaratne, G. S., Yang, Y., Li, F., Walseth, T. F. &amp; Marchant, J. S. NAADP-dependent Ca(2+) signaling regulates Middle East respiratory syndrome-coronavirus pseudovirus translocation through the endolysosomal system. Cell Calcium75, 30â41 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6251489</ArticleId><ArticleId IdType="pubmed">30121440</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou, X. et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun.11, 1620 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7100515</ArticleId><ArticleId IdType="pubmed">32221306</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadonaite, B. et al. A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike. Cell186, 1263â1278.e1220 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9922669</ArticleId><ArticleId IdType="pubmed">36868218</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott, J. B. et al. Immunobiology of Ebola and Lassa virus infections. Nat. Rev. Immunol.17, 195â207 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28111475</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons, J. A. et al. Ebolavirus glycoprotein directs fusion through NPC1+ endolysosomes. J. Virol.90, 605â610 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702577</ArticleId><ArticleId IdType="pubmed">26468524</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, I. S. et al. Mechanism of membrane fusion induced by vesicular stomatitis virus G protein. Proc. Natl. Acad. Sci. USA114, E28âE36 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5224367</ArticleId><ArticleId IdType="pubmed">27974607</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche, S. &amp; Gaudin, Y. Evidence that rabies virus forms different kinds of fusion machines with different pH thresholds for fusion. J. Virol.78, 8746â8752 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC479077</ArticleId><ArticleId IdType="pubmed">15280482</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, S. et al. Acidic pH-induced conformations and LAMP1 binding of the lassa virus glycoprotein spike. PLoS Pathog.12, e1005418 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4743923</ArticleId><ArticleId IdType="pubmed">26849049</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J. et al. Structure of the Ebola virus envelope protein MPER/TM domain and its interaction with the fusion loop explains their fusion activity. Proc. Natl. Acad. Sci. USA114, E7987âE7996 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5617291</ArticleId><ArticleId IdType="pubmed">28874543</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Simone, C. &amp; Buchmeier, M. J. Kinetics and pH dependence of acid-induced structural changes in the lymphocytic choriomeningitis virus glycoprotein complex. Virology209, 3â9 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7747483</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J. et al. Ebola virus glycoprotein interacts with cholesterol to enhance membrane fusion and cell entry. Nat. Struct. Mol. Biol.28, 181â189 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7992113</ArticleId><ArticleId IdType="pubmed">33462517</ArticleId></ArticleIdList></Reference><Reference><Citation>Turk, B. et al. Acidic pH as a physiological regulator of human cathepsin L activity. Eur. J. Biochem.259, 926â932 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10092883</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan, H. A., van Zoelen, E. J. &amp; van Leeuwen, J. E. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination. J. Biol. Chem.278, 35781â35790 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12829707</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin, X. et al. Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels. Br. J. Pharm.168, 1294â1312 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3596637</ArticleId><ArticleId IdType="pubmed">23145923</ArticleId></ArticleIdList></Reference><Reference><Citation>Chubanov, V. &amp; Gudermann, T. Mapping TRPM7 function by NS8593. Int. J. Mol. Sci21, 7017 (2020)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7582524</ArticleId><ArticleId IdType="pubmed">32977698</ArticleId></ArticleIdList></Reference><Reference><Citation>Chubanov, V. et al. Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7. Br. J. Pharm.166, 1357â1376 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3417452</ArticleId><ArticleId IdType="pubmed">22242975</ArticleId></ArticleIdList></Reference><Reference><Citation>Rost, B. R. et al. Optogenetic acidification of synaptic vesicles and lysosomes. Nat. Neurosci.18, 1845â1852 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4869830</ArticleId><ArticleId IdType="pubmed">26551543</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell181, 271â280.e278 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayati, A., Kumar, R., Francis, V. &amp; McPherson, P. S. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J. Biol. Chem.296, 100306 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816624</ArticleId><ArticleId IdType="pubmed">33476648</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch, J. et al. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells. EMBO J.40, e107821 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8365257</ArticleId><ArticleId IdType="pubmed">34159616</ArticleId></ArticleIdList></Reference><Reference><Citation>Birtles, D., Oh, A. E. &amp; Lee, J. Exploring the pH dependence of the SARS-CoV-2 complete fusion domain and the role of its unique structural features. Protein Sci.31, e4390 (2022)</Citation></Reference><Reference><Citation>Zang, R. et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci. Immunol.5. 10.1126/sciimmunol.abc3582 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7285829</ArticleId><ArticleId IdType="pubmed">32404436</ArticleId></ArticleIdList></Reference><Reference><Citation>Graler, M. H. &amp; Goetzl, E. J. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J.18, 551â553 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14715694</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmann, V. et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem.277, 21453â21457 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11967257</ArticleId></ArticleIdList></Reference><Reference><Citation>Galloway, S. E., Reed, M. L., Russell, C. J. &amp; Steinhauer, D. A. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog.9, e1003151 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3573126</ArticleId><ArticleId IdType="pubmed">23459660</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, Y. M., Sneyd, H., Dekant, R. &amp; Wang, J. Influenza A virus nucleoprotein: a highly conserved multi-functional viral protein as a hot antiviral drug target. Curr. Top. Med. Chem.17, 2271â2285 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5967877</ArticleId><ArticleId IdType="pubmed">28240183</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouvier, N. M. &amp; Lowen, A. C. Animal models for influenza virus pathogenesis and transmission. Viruses2, 1530â1563 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3063653</ArticleId><ArticleId IdType="pubmed">21442033</ArticleId></ArticleIdList></Reference><Reference><Citation>De Clercq, E. &amp; Li, G. Approved antiviral drugs over the past 50 years. Clin. Microbiol Rev.29, 695â747 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4978613</ArticleId><ArticleId IdType="pubmed">27281742</ArticleId></ArticleIdList></Reference><Reference><Citation>Drose, S. &amp; Altendorf, K. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol.200, 1â8 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9023991</ArticleId></ArticleIdList></Reference><Reference><Citation>Osei-Owusu, J. et al. Proton-activated chloride channel PAC regulates endosomal acidification and transferrin receptor-mediated endocytosis. Cell Rep.34, 108683 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869721</ArticleId><ArticleId IdType="pubmed">33503418</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson, C. B., Farzan, M., Chen, B. &amp; Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol.23, 3â20 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreutzberger, A. J. B. et al. Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease. J. Virol.95, e0097521 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8513479</ArticleId><ArticleId IdType="pubmed">34406858</ArticleId></ArticleIdList></Reference><Reference><Citation>Case, J. B. et al. Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis in mice. Cell Host Microbe28, 465â474.e464 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391951</ArticleId><ArticleId IdType="pubmed">32798445</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelan, S. P., Ball, L. A., Barr, J. N. &amp; Wertz, G. T. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc. Natl. Acad. Sci. USA92, 8388â8392 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC41162</ArticleId><ArticleId IdType="pubmed">7667300</ArticleId></ArticleIdList></Reference><Reference><Citation>Case, J. B. et al. Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2. Cell Host Microbe28, 475â485.e475 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332453</ArticleId><ArticleId IdType="pubmed">32735849</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuerst, T. R., Niles, E. G., Studier, F. W. &amp; Moss, B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA83, 8122â8126 (1986).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC386879</ArticleId><ArticleId IdType="pubmed">3095828</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguet, F. et al. Membrane dynamics of dividing cells imaged by lattice light-sheet microscopy. Mol. Biol. Cell27, 3418â3435 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5221578</ArticleId><ArticleId IdType="pubmed">27535432</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou, Y. Y. et al. Inherited nuclear pore substructures template post-mitotic pore assembly. Dev. Cell56, 1786â1803.e1789 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8261643</ArticleId><ArticleId IdType="pubmed">34129835</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabot, M., Kiessling, V., White, J. M. &amp; Tamm, L. K. Endosomes supporting fusion mediated by vesicular stomatitis virus glycoprotein have distinctive motion and acidification. Traffic23, 221â234 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10621750</ArticleId><ArticleId IdType="pubmed">35147273</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>